Henick B, Taylor A, Nakagawa H, Wong K, Diehl J, Rustgi A
Cancer Cell. 2025; 43(2):178-194.
PMID: 39933897
PMC: 11875029.
DOI: 10.1016/j.ccell.2025.01.003.
Schirripa A, Schoppe H, Nebenfuehr S, Zojer M, Klampfl T, Kugler V
iScience. 2025; 28(2):111697.
PMID: 39898030
PMC: 11787673.
DOI: 10.1016/j.isci.2024.111697.
Yuki S, Sasaki S, Yamamoto Y, Murakami F, Sakata K, Araki I
Genes Cells. 2024; 29(11):1037-1051.
PMID: 39380239
PMC: 11555623.
DOI: 10.1111/gtc.13165.
OSullivan E, Wallis R, Mossa F, Bishop C
NPJ Aging. 2024; 10(1):41.
PMID: 39277623
PMC: 11401916.
DOI: 10.1038/s41514-024-00168-y.
Lavernia J, Claramunt R, Romero I, Lopez-Guerrero J, Llombart-Bosch A, Machado I
Cancers (Basel). 2024; 16(2).
PMID: 38275873
PMC: 10814159.
DOI: 10.3390/cancers16020432.
Publication Trends and Hot Topics in Dysplastic Nevus Research: A 30-Year Bibliometric Analysis.
Izol Ozmen H
Dermatol Pract Concept. 2023; 13(4).
PMID: 37992349
PMC: 10656159.
DOI: 10.5826/dpc.1304a266.
Cyclin-dependent kinases: Masters of the eukaryotic universe.
Pluta A, Studniarek C, Murphy S, Norbury C
Wiley Interdiscip Rev RNA. 2023; :e1816.
PMID: 37718413
PMC: 10909489.
DOI: 10.1002/wrna.1816.
Noncanonical CDK4 signaling rescues diabetes in a mouse model by promoting β cell differentiation.
Stamateris R, Landa-Galvan H, Sharma R, Darko C, Redmond D, Rane S
J Clin Invest. 2023; 133(18).
PMID: 37712417
PMC: 10503800.
DOI: 10.1172/JCI166490.
Common Marmoset Cell Lines and Their Applications in Biomedical Research.
Bayurova E, Zhitkevich A, Avdoshina D, Kupriyanova N, Kolyako Y, Kostyushev D
Cells. 2023; 12(16).
PMID: 37626830
PMC: 10453182.
DOI: 10.3390/cells12162020.
CDK4-E2F3 signals enhance oxidative skeletal muscle fiber numbers and function to affect myogenesis and metabolism.
Bahn Y, Yadav H, Piaggi P, Abel B, Gavrilova O, Springer D
J Clin Invest. 2023; 133(13).
PMID: 37395281
PMC: 10313363.
DOI: 10.1172/JCI162479.
Hypoxia in Skin Cancer: Molecular Basis and Clinical Implications.
Jeon S, Jeon M, Choi S, Yoo S, Park S, Lee M
Int J Mol Sci. 2023; 24(5).
PMID: 36901857
PMC: 10003002.
DOI: 10.3390/ijms24054430.
The Complex Interplay between Nevi and Melanoma: Risk Factors and Precursors.
Shreberk-Hassidim R, Ostrowski S, Fisher D
Int J Mol Sci. 2023; 24(4).
PMID: 36834954
PMC: 9964821.
DOI: 10.3390/ijms24043541.
New Insights into Melanoma Tumor Syndromes.
Rashid S, Gupta S, McCormick S, Tsao H
JID Innov. 2022; 2(6):100152.
PMID: 36387771
PMC: 9641259.
DOI: 10.1016/j.xjidi.2022.100152.
Mutually exclusive genetic interactions and gene essentiality shape the genomic landscape of primary melanoma.
Birkealv S, Harland M, Matsuyama L, Rashid M, Mehta I, Laye J
J Pathol. 2022; 259(1):56-68.
PMID: 36219477
PMC: 10098817.
DOI: 10.1002/path.6019.
Gene Regulations upon Hydrogel-Mediated Drug Delivery Systems in Skin Cancers-An Overview.
Mathiyalagan R, Valappil A, Yang D, Kang S, Thambi T
Gels. 2022; 8(9).
PMID: 36135270
PMC: 9498739.
DOI: 10.3390/gels8090560.
CDK4: a master regulator of the cell cycle and its role in cancer.
Baker S, Poulikakos P, Irie H, Parekh S, Reddy E
Genes Cancer. 2022; 13:21-45.
PMID: 36051751
PMC: 9426627.
DOI: 10.18632/genesandcancer.221.
Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities.
Zabihi M, Lotfi R, Yousefi A, Bashash D
J Cancer Res Clin Oncol. 2022; 149(4):1585-1606.
PMID: 35781526
DOI: 10.1007/s00432-022-04135-6.
Nuclear focal adhesion kinase induces APC/C activator protein CDH1-mediated cyclin-dependent kinase 4/6 degradation and inhibits melanoma proliferation.
Murphy J, Jeong K, Ahn E, Lim S
J Biol Chem. 2022; 298(6):102013.
PMID: 35525274
PMC: 9163754.
DOI: 10.1016/j.jbc.2022.102013.
Defining novel causal SNPs and linked phenotypes at melanoma-associated loci.
Castaneda-Garcia C, Iyer V, Nsengimana J, Trower A, Droop A, Brown K
Hum Mol Genet. 2022; 31(17):2845-2856.
PMID: 35357426
PMC: 9433725.
DOI: 10.1093/hmg/ddac074.
Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040.
Arnold M, Singh D, Laversanne M, Vignat J, Vaccarella S, Meheus F
JAMA Dermatol. 2022; 158(5):495-503.
PMID: 35353115
PMC: 8968696.
DOI: 10.1001/jamadermatol.2022.0160.
